Antimicrobial agents in patients with renal insufficiency
Related Experiment Videos
Abstract:
The dosage or the time interval of administration (or both) of many antimicrobial agents must be adjusted in anephric patients or those with compromised renal function. Antimicrobial agents that must be adjusted include most but not all of the penicillins, the cephalosporins, the aminoglycosides, vancomycin, and trimethoprim-sulfamethoxazole. The maximal doses of these agents should be decreased in proportion to the reduction of renal function. The dosage of chloramphenicol, clindamycin, rifampin, oxacillin, and nafcillin probably need not be adjusted if hepatic function is essentially normal. The suggested doses are relatively crude guidelines to initial antimicrobial therapy. Administration of the initial dose should be followed by serum antimicrobial assays for accurate adjustment of the dosage. The efficacy of therapy and the possible occurrence of toxicity should be carefully monitored in all patients but particularly in those with renal insufficiency.
Insights
Renal impairment necessitates adjusting doses for many antimicrobial drugs, including penicillins, cephalosporins, and aminoglycosides. Careful monitoring and serum drug assays ensure safe and effective antimicrobial therapy in patients with reduced kidney function.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Many antimicrobial agents require dose adjustments in patients with impaired renal function or anuria.
- Specific drug classes commonly affected include penicillins, cephalosporins, aminoglycosides, vancomycin, and trimethoprim-sulfamethoxazole.
Purpose of the Study:
- To provide guidelines for adjusting antimicrobial dosages in patients with compromised renal function.
- To highlight antimicrobial agents that may not require dose modification in the presence of normal hepatic function.
Main Methods:
- Review of antimicrobial agents requiring dosage adjustments based on renal function.
- Identification of antimicrobials potentially safe from dose adjustment if hepatic function is normal.
- Emphasis on the need for therapeutic drug monitoring via serum antimicrobial assays.
Main Results:
- Most penicillins, cephalosporins, aminoglycosides, vancomycin, and trimethoprim-sulfamethoxazole require dose reduction proportional to renal function.
- Chloramphenicol, clindamycin, rifampin, oxacillin, and nafcillin may not need dose adjustment with normal liver function.
- Initial doses serve as crude guidelines; subsequent adjustments based on serum assays are crucial.
Conclusions:
- Antimicrobial dosing must be individualized for patients with renal insufficiency.
- Therapeutic drug monitoring and close observation for efficacy and toxicity are essential.
- Accurate dose adjustment ensures optimal outcomes in patients with kidney dysfunction.